AZN vs. MNG.L
AZN (AstraZeneca PLC) and MNG.L (M&G plc) are both stocks. AZN operates in Drug Manufacturers - General (Healthcare), while MNG.L operates in Asset Management (Financial Services). Over the past 5 years, AZN returned 12.08%/yr vs 13.76%/yr for MNG.L. At a 0.16 correlation, their price movements are largely independent.
Performance
AZN vs. MNG.L - Performance Comparison
Loading charts...
Different Trading Currencies
AZN is traded in USD, while MNG.L is traded in GBp. To make them comparable, the MNG.L values have been converted to USD using the latest available exchange rates.
Returns By Period
In the year-to-date period, AZN achieves a 0.81% return, which is significantly lower than MNG.L's 13.54% return.
AZN
- 1D
- -2.37%
- 1M
- -0.71%
- YTD
- 0.81%
- 6M
- 1.53%
- 1Y
- 28.04%
- 3Y*
- 9.54%
- 5Y*
- 12.08%
- 10Y*
- 15.85%
MNG.L
- 1D
- 0.44%
- 1M
- 1.30%
- YTD
- 13.54%
- 6M
- 20.50%
- 1Y
- 36.24%
- 3Y*
- 28.74%
- 5Y*
- 13.76%
- 10Y*
- —
AZN vs. MNG.L - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
AZN AstraZeneca PLC | 0.81% | 43.30% | -0.62% | 1.44% | 19.14% | 19.66% | 3.12% | 13.65% |
MNG.L M&G plc | 13.54% | 70.40% | -4.29% | 38.09% | -8.45% | 8.92% | -8.62% | 10.24% |
Correlation
The correlation between AZN and MNG.L is 0.17, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.17 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.20 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.20 |
Correlation (All Time) Calculated using the full available price history since Oct 21, 2019 | 0.16 |
Fundamentals
AZN:
$283.40B
MNG.L:
£8.01B
AZN:
$6.66
MNG.L:
-£0.02
AZN:
4.69
MNG.L:
0.29
AZN:
5.99
MNG.L:
2.56
AZN:
$60.44B
MNG.L:
£27.20B
AZN:
$49.37B
MNG.L:
£28.73B
AZN:
$20.47B
MNG.L:
£2.40B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
AZN vs. MNG.L — Risk / Return Rank
AZN
MNG.L
AZN vs. MNG.L - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for AstraZeneca PLC (AZN) and M&G plc (MNG.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| AZN | MNG.L | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.68 | ||
| Sortino ratioReturn per unit of downside risk | -0.66 | ||
| Omega ratioGain probability vs. loss probability | 1.21 | 1.31 | -0.10 |
| Calmar ratioReturn relative to maximum drawdown | 1.83 | 2.65 | -0.82 |
| Martin ratioReturn relative to average drawdown | 4.90 | 9.97 | -5.07 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| AZN | MNG.L | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.11 | 1.79 | -0.68 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.51 | 0.51 | -0.01 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.64 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.49 | 0.40 | +0.10 |
Drawdowns
AZN vs. MNG.L - Drawdown Comparison
The maximum AZN drawdown since its inception was -48.94%, smaller than the maximum MNG.L drawdown of -66.60%. Use the drawdown chart below to compare losses from any high point for AZN and MNG.L.
Loading charts...
Drawdown Indicators
| AZN | MNG.L | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -48.94% | -66.60% | +17.66% |
Max Drawdown (1Y)Largest decline over 1 year | -15.43% | -13.59% | -1.84% |
Max Drawdown (3Y)Largest decline over 3 years | -27.87% | -20.15% | -7.72% |
Max Drawdown (5Y)Largest decline over 5 years | -27.87% | -42.56% | +14.69% |
Max Drawdown (10Y)Largest decline over 10 years | -27.87% | — | — |
Current DrawdownCurrent decline from peak | -12.90% | -1.73% | -11.17% |
Average DrawdownAverage peak-to-trough decline | -11.37% | -13.92% | +2.55% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.75% | 3.63% | +2.12% |
Volatility
AZN vs. MNG.L - Volatility Comparison
AstraZeneca PLC (AZN) has a higher volatility of 7.42% compared to M&G plc (MNG.L) at 5.79%. This indicates that AZN's price experiences larger fluctuations and is considered to be riskier than MNG.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| AZN | MNG.L | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.42% | 5.79% | +1.63% |
Volatility (6M)Calculated over the trailing 6-month period | 17.47% | 16.16% | +1.31% |
Volatility (1Y)Calculated over the trailing 1-year period | 25.55% | 20.24% | +5.31% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 24.02% | 26.89% | -2.87% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 24.94% | 38.87% | -13.93% |
Dividends
AZN vs. MNG.L - Dividend Comparison
AZN's dividend yield for the trailing twelve months is around 2.93%, less than MNG.L's 6.55% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
AZN AstraZeneca PLC | 2.93% | 1.70% | 2.27% | 2.15% | 2.12% | 2.35% | 2.80% | 2.81% | 3.69% | 3.95% | 5.01% | 4.06% |
MNG.L M&G plc | 6.55% | 7.05% | 10.01% | 8.95% | 9.80% | 9.19% | 4.98% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
AZN vs. MNG.L - Financials Comparison
This section allows you to compare key financial metrics between AstraZeneca PLC and M&G plc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
AZN vs. MNG.L - Profitability Comparison
AZN - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, AstraZeneca PLC reported a gross profit of 12.61B and revenue of 15.29B. Therefore, the gross margin over that period was 82.5%.
MNG.L - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, M&G plc reported a gross profit of 13.84B and revenue of 13.84B. Therefore, the gross margin over that period was 100.0%.
AZN - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, AstraZeneca PLC reported an operating income of 4.25B and revenue of 15.29B, resulting in an operating margin of 27.8%.
MNG.L - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, M&G plc reported an operating income of 751.00M and revenue of 13.84B, resulting in an operating margin of 5.4%.
AZN - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, AstraZeneca PLC reported a net income of 3.08B and revenue of 15.29B, resulting in a net margin of 20.2%.
MNG.L - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, M&G plc reported a net income of 59.00M and revenue of 13.84B, resulting in a net margin of 0.4%.
Frequently Asked Questions
AZN and MNG.L have a correlation of 0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for AZN and MNG.L
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer